Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Elotuzumab

EU orphan designation number: EU/3/12/1037
Active ingredient: Elotuzumab
Indication: Treatment of multiple myeloma
Sponsor: Bristol-Myers Squibb Pharma EEIG
Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/08/2012 Orphan designation EMA/OD/061/12 (2012)5800 of 09/08/2012
08/04/2016 Removal of orphan designation from Community Register